Trials / Conditions / Venous Thromboembolic Disease

Venous Thromboembolic Disease

27 registered clinical trials studyying Venous Thromboembolic Disease — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism NCT04211181	China-Japan Friendship Hospital	N/A
Recruiting	Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Maligna NCT07270263	Medical University of Gdansk	N/A
Recruiting	THROmbinography in Pregnant Woman and in Vitro Action of Low Molecular Weight HEparin NCT06575309	University Hospital, Clermont-Ferrand	—
Recruiting	Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboe NCT06232551	Scott C. Woller, MD	N/A
Recruiting	Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets NCT05627375	Centre Hospitalier Universitaire de Saint Etienne	Phase 3
Unknown	Comparison of the 'CTR' Ratio With Standard Haemostasis Parameters in the Follow-up of Patients Undergoing Hep NCT05993533	Direction Centrale du Service de Santé des Armées	—
Unknown	Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Pati NCT05515549	Qianfoshan Hospital	—
Recruiting	Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune He NCT05089227	Centre Hospitalier Universitaire Dijon	Phase 2
Unknown	CHIPs-VTE Study in Hospitalized Patients With Lung Cancer NCT04158973	China-Japan Friendship Hospital	N/A
Unknown	Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking Enoxaparin NCT05150314	University Hospital, Strasbourg, France	—
Active Not Recruiting	Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective S NCT05396157	Mount Sinai Hospital, Canada	—
Completed	Clotting Parameters After Medical Abortion NCT04824118	NHS Lothian	—
Completed	Anticoagulation Strategies for Acute Venous Thromboembolism in Patients With End-Stage Renal Disease Using USR NCT04818151	Johns Hopkins University	—
Recruiting	Cohort for Monitoring Patients With Venous Thromboembolic Disease NCT07016542	University Hospital, Rouen	—
Unknown	Screening for Cancer in Patients With Unprovoked VTE NCT03937583	Fundación Pública Andaluza para la gestión de la Investigación en Sevilla	Phase 4
Completed	Predictors of Attempted Inferior Vena Cava Filters Retrieval. NCT04846725	Centre Hospitalier Universitaire de Saint Etienne	—
Unknown	Cost Effectiveness Analysis of an Ancillary Study of the REMOTEV Study NCT03887806	University Hospital, Strasbourg, France	—
Completed	Association Between Genetic Variant Scores and Warfarin Effect NCT03894878	Cipherome, Inc.	—
Recruiting	Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure NCT03206372	University Hospital, Brest	—
Unknown	Long-term Outcome After Edoxaban Versus Vitamin K Antagonists for Acute VTE NCT04007653	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	—
Completed	Registry of Angiovac Procedures In Detail Outcomes Database-RAPID Registry NCT04414332	University of California, Los Angeles	—
Completed	Observational Prospectif Monocentric Registry of Patients Suffering From VIE NCT02188056	University Hospital, Strasbourg, France	—
Completed	Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day En NCT01729559	Scripps Health	Phase 4
Completed	The Role of FDG-PET/CT Imaging in the Management of Patients With Thromboembolic Disorders (The PETVET Study) NCT01466426	Odense University Hospital	—
Active Not Recruiting	Genetic Testing of CYP2C19 in Prognostic Evaluation of Long-Term Major Adverse Cardiac and Vascular Events NCT06855394	University of Florida	—
Unknown	Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulat NCT00691470	ARYx Therapeutics	Phase 2 / Phase 3
Completed	Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter. NCT00556426	C. R. Bard	N/A